Thompson Siegel & Walmsley’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$51.9M Sell
3,838,892
-1,722,475
-31% -$24.1M 0.91% 34
2025
Q4
$69.2M Sell
5,561,367
-2,092,653
-27% -$22.6M 1.16% 16
2025
Q3
$75.8M Buy
7,654,020
+1,137,890
+17% +$11.1M 1.22% 16
2025
Q2
$58.2M Buy
6,516,130
+252,551
+4% +$2.14M 0.97% 35
2025
Q1
$54.6M Buy
6,263,579
+833,931
+15% +$8.76M 0.92% 42
2024
Q4
$67.6M Sell
5,429,648
-501,256
-8% -$6.16M 1.05% 31
2024
Q3
$68.9M Sell
5,930,904
-106,285
-2% -$1.23M 1.03% 31
2024
Q2
$64.2M Buy
6,037,189
+2,285,921
+61% +$25.3M 1.03% 33
2024
Q1
$44.8M Buy
3,751,268
+3,746,439
+77,582% +$45.1M 0.69% 54
2023
Q4
$52K Sell
4,829
-93
-2% -$891 ﹤0.01% 417
2023
Q3
$49K Sell
4,922
-61
-1% -$635 ﹤0.01% 418
2023
Q2
$50K Sell
4,983
-162
-3% -$1.55K ﹤0.01% 422
2023
Q1
$49K Sell
5,145
-240
-4% -$2.66K ﹤0.01% 425
2022
Q4
$60K Sell
5,385
-263
-5% -$2.75K ﹤0.01% 408
2022
Q3
$48K Sell
5,648
-839
-13% -$8.26K ﹤0.01% 421
2022
Q2
$68K Sell
6,487
-3,683,952
-100% -$40.4M ﹤0.01% 399
2022
Q1
$40.2M Sell
3,690,439
-73,912
-2% -$974K 0.57% 63
2021
Q4
$50.9M Sell
3,764,351
-321,810
-8% -$4.3M 0.7% 51
2021
Q3
$55.4M Sell
4,086,161
-319,837
-7% -$4.54M 0.8% 45
2021
Q2
$63M Buy
4,405,998
+762,566
+21% +$11M 0.86% 45
2021
Q1
$50.9M Buy
3,643,432
+1,892,108
+108% +$30.8M 0.73% 50
2020
Q4
$32.8M Buy
1,751,324
+175,364
+11% +$2.86M 0.53% 67
2020
Q3
$23.4M Buy
+1,575,960
New +$25.2M 0.45% 67
2019
Q2
Sell
-1,100
Closed -$31K 787
2019
Q1
$31K Hold
1,100
﹤0.01% 533
2018
Q4
$30K Hold
1,100
﹤0.01% 536
2018
Q3
$40K Hold
1,100
﹤0.01% 545
2018
Q2
$40K Sell
1,100
-200
-15% -$7.85K ﹤0.01% 554
2018
Q1
$54K Sell
1,300
-625
-32% -$26.6K ﹤0.01% 517
2017
Q4
$81K Sell
1,925
-55,050
-97% -$2.1M ﹤0.01% 490
2017
Q3
$1.79M Buy
+56,975
New +$1.93M 0.02% 273
2015
Q3
Sell
-1,900
Closed -$129K 717
2015
Q2
$129K Buy
+1,900
New +$134K ﹤0.01% 409

Other funds holding VTRS

Thompson Siegel & Walmsley's VTRS Position: Q1 2026 in Review

Thompson Siegel & Walmsley reduced its Viatris (VTRS) stake by 31% in Q1 2026, selling an estimated $24.1M and leaving 3,838,892 shares worth $51.9M. The position accounts for 0.91% of the portfolio, ranked #34.

Thompson Siegel & Walmsley first reported a position in VTRS in Q2 2015 and has held it in 31 quarters since. The position peaked at $75.8M in Q3 2025. 1,019 funds tracked by Wall St. Rank hold VTRS as of Q1 2026.

  • Thompson Siegel & Walmsley held 3,838,892 shares of Viatris worth $51.9M as of Q1 2026.
  • Thompson Siegel & Walmsley sold 1,722,475 Viatris shares in Q1 2026, an estimated $24.1M.
  • Viatris made up 0.91% of Thompson Siegel & Walmsley's portfolio in Q1 2026, its #34 holding.
  • Thompson Siegel & Walmsley first reported a position in Viatris in Q2 2015 and has held it in 31 quarters since.
  • Thompson Siegel & Walmsley's Viatris position peaked at $75.8M in Q3 2025.
  • 1,019 funds tracked by Wall St. Rank held Viatris as of Q1 2026.

Based on Thompson Siegel & Walmsley's 13F filing for Q1 2026, filed 11 May 2026.